Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Ibuprofen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Breast Neoplasms 3 Trigger Finger Disorder 2 Prostatic Neoplasms 2 Pain 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Inflammation 2 Ganglion Cysts 2 De Quervain Disease 2 Cachexia 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Supratentorial Brain Tumor 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatitis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary Neoplasms 1 Patient Satisfaction 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Mucositis 1 Menorrhagia 1 Melanoma 1 Median Neuropathy 1 Leiomyoma 1 Kidney Neoplasms 1 Hemorrhage 1

Interventions

pembrolizumab 262 Nivolumab 238 Ipilimumab 217 aldesleukin 123 Cyclophosphamide 122 Interleukin-2 91 trametinib 75 dabrafenib 68 Dacarbazine 67 fludarabine 63 Vemurafenib 63 Temozolomide 62 fludarabine phosphate 55 Radiosurgery 43 Biopsy 43 Bevacizumab 40 sargramostim 39 binimetinib 36 incomplete Freund's adjuvant 35 Paclitaxel 34 atezolizumab 33 Radiotherapy 33 Cisplatin 33 Magnetic Resonance Spectroscopy 32 Blood Specimen Collection 32 Specimen Handling 31 Introns 31 encorafenib 30 cobimetinib 30 Carboplatin 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00111046 2005-11-10

Pain Relief - Tramadol Versus Ibuprofen

Royal Liverpool University Hospital

Phase 1/2 Unknown

Uveal Melanoma, Eye Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡